340B Under Siege: $8B Clawback + Lilly Lawsuit
Supply Chain Pulse — 2026-07-16
The 340B Drug Pricing Program is having a very bad week. The government is making another run at clawing back nearly $8 billion from providers following the 2022 Supreme Court ruling — and separately, Tampa General just sued Eli Lilly for freezing 340B discounts over a claims-data standoff. If your health system depends on 340B savings to fund pharmacy operations or underserved-population care, these two stories are moving in the same uncomfortable direction. Watch closely: how courts and CMS land on these disputes will set the financial floor — or ceiling — for 340B-dependent organizations heading into budget season.
Quick Hits
Tampa General Sues Eli Lilly Over 340B Discount Freeze
Tampa General Hospital has filed suit against Eli Lilly after the pharma giant withheld 340B discounts from hospitals that refused to share claims data — a condition Lilly imposed unilaterally and that providers argue violates the program's terms. For supply chain and pharmacy leaders, this is a direct threat to drug acquisition cost structures that many safety-net hospitals have built their financial models around. The outcome could set a precedent for whether manufacturers can use data-sharing demands as leverage to effectively opt out of 340B obligations.
Why the 340B Payment Fight Is Flaring Up Again
Following the Supreme Court's 2022 ruling that CMS had improperly cut 340B reimbursement rates, the government is now pursuing a roughly $8 billion clawback from providers who received back-payments — a move that could significantly reverse the financial relief hospitals thought they'd won. The ongoing legal and regulatory turbulence makes 340B savings projections nearly impossible to lock in, complicating multi-year pharmacy and supply budgets. If your GPO strategy or formulary decisions are tied to 340B assumptions, it's time to model the downside scenario.
Allegheny Health Network Closes Deal to Buy Heritage Valley
Allegheny Health Network has completed its acquisition of Heritage Valley, adding two hospitals and approximately 500 physicians to its footprint in the Pittsburgh region — though the deal came with court-imposed conditions reflecting ongoing regulatory scrutiny of health system consolidation. For supply chain teams at both organizations, integration work starts now: contract alignment, GPO consolidation, and physician preference item standardization across a significantly larger network. Deals of this scale typically take 18–24 months to yield procurement synergies, so setting realistic timelines early is critical.
Ascension Outbids HCA, Optum for Williamson Health
Ascension beat out HCA Healthcare and Optum to acquire Williamson Health, which operates a hospital in Franklin, Tennessee — one of the fastest-growing and highest-income markets in the Southeast. The competitive bidding signals continued appetite for well-positioned community hospitals despite broader health system financial pressures, and Ascension's win adds a strategically valuable asset to its regional network. Supply chain leaders at Ascension affiliates should anticipate the usual integration timeline: expect vendor contract reviews and standardization discussions to begin within the next two quarters.
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe